Abstract
Get full access to this article
View all access options for this article.
References
1.
Stadtmauer
EA
,
Fraietta
JA
,
Davis
MM
et al. CRISPR-engineered T cells in patients with refractory cancer . Science , 2020 . DOI:10.1126/science.aba7365